Skip to content

13F-HR filed by JOHNSON & JOHNSON

JOHNSON & JOHNSON filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-11, with 23 holding rows worth $307,422,214.

Accession
0000904454-23-000307
Filed
2023-05-11
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2023

A holdings report, 23 entries on the cover page, a total value of $307,422,214 stated on the cover page (in dollars after the unit check, H1), rows summing to $307,422,214 with VALUE read as dollars as filed, 13F file number 028-20072. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LEGEND BIOTECH CORP52490G102SPONSORED ADS1,629,173$78,558,722dollars as filed
PROTAGONIST THERAPEUTICS74366E102COM2,449,183$56,331,209dollars as filed
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK6,641,064$34,334,301dollars as filed
CVRX INC126638105COMMON STOCK3,495,575$32,578,759dollars as filed
XENCOR INC98401F105COMMON STOCK748,062$20,863,449dollars as filed
FATE THERAPEUTICS INC31189P102COM3,379,064$19,260,665dollars as filed
FUSION PHARMACEUTICALS INC36118A100COM3,670,516$13,837,845dollars as filed
PROCEPT BIOROBOTICS CORP COM74276L105Stock357,939$10,165,468dollars as filed
CUE HEALTH INC229790100COM5,548,864$10,098,932dollars as filed
POINT BIOPHARMA GLOBAL INC730541109COM1,000,000$7,270,000dollars as filed
ARROWHEAD PHARMACEUTICALS IN04280A100COM247,598$6,288,989dollars as filed
VOR BIOPHARMA INC929033108COM1,074,658$5,781,660dollars as filed
ADICET BIO INC007002108COM728,944$4,198,717dollars as filed
ALDEYRA THERAPEUTICS INC01438T106COM394,834$3,920,702dollars as filed
NANO X IMAGING LTDM70700105ORD SHS317,704$1,833,152dollars as filed
SOMALOGIC INC83444K105COM281,052$716,683dollars as filed
BIOMX INC09090D103COM2,133,402$650,688dollars as filed
APOLLOMICS INCG0411D107COM13,252$320,698dollars as filed
CLEARSIDE BIOMEDICAL INC185063104COM169,629$176,414dollars as filed
TRACON PHARMACEUTICALS INC89237H209COM NEW84,003$158,766dollars as filed
SENSEONICS HLDGS INC81727U105COM54,621$38,781dollars as filed
VISTAGEN THERAPEUTICS INC92840H202COM190,494$23,755dollars as filed
CATALYST BIOSCIENCES INC14888D208COM66,951$13,859dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000904454-23-000307this filing2023-05-11acceptance time not in the bulk data set